Cargando…
Letter #1 Response to letter to Editor by Dr. Sarkar et al. for’ who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to letter to Editor by Dr. Hantoushzadeh et al. for’ is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?’ Refers to PII: S2210-7789(21)00538-9
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716314/ https://www.ncbi.nlm.nih.gov/pubmed/34973599 http://dx.doi.org/10.1016/j.preghy.2021.11.002 |